Pancreatic Cancer Research

ResearcherXiamen UniversityActive in the last 2 years

Yu Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0008-1769-9387; OpenAlex author ID A5100445410. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 2 papers · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. CAF-derived PAI-1 serves as an EGFR ligand and fuels KRAS-mutant pancreatic cancer. Co-author DOI 10.1038/s41467-026-75132-3↗
  2. Value of thyroid cancer history in the prognosis of pancreatic cancer: a SEER population-based study. First author DOI 10.1038/s41598-023-32635-z↗
  3. The role of BHLHE40 in clinical features and prognosis value of PDAC by comprehensive analysis and in vitro validation. Co-author DOI 10.3389/fonc.2023.1151321↗
  4. Systematic Analysis of an Invasion-Related 3-Gene Signature and Its Validation as a Prognostic Model for Pancreatic Cancer. First author DOI 10.3389/fonc.2021.759586↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xuan Zhou · 2 shared papers, 2023–2026 · strength 0.37
  2. Jun He · 1 shared paper, 2023 · strength 0.24
  3. Jianyin Zhou · 1 shared paper, 2023 · strength 0.24
  4. Min Li · 1 shared paper, 2026 · strength 0.21
  5. Bo Wang · 1 shared paper, 2026 · strength 0.21
  6. Quan Zhou · 1 shared paper, 2026 · strength 0.21
  7. Xiaofan Guo · 1 shared paper, 2026 · strength 0.21
  8. Tianxing Zhou · 1 shared paper, 2026 · strength 0.21
  9. Jihui Hao · 1 shared paper, 2026 · strength 0.21
  10. Lei Zheng · 1 shared paper, 2026 · strength 0.21
  11. Mien‐Chie Hung · 1 shared paper, 2026 · strength 0.21
  12. Chao Liu · 1 shared paper, 2023 · strength 0.16
  13. Song Gao · 1 shared paper, 2023 · strength 0.16
  14. Dafeng Xu · 1 shared paper, 2021 · strength 0.16
  15. Jinfang Zheng · 1 shared paper, 2021 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.